Advertisement
Heather Bresch
Healthcare
28 April, 2015
Mylan rejects Teva Pharma's $40B takeover offer
Generic drug-maker Mylan Inc's board has unanimously rejected the proposed $40 billion takeover bid by Israel-based Teva Pharmaceutical Industries Ltd, ......